|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Cleveland BioLabs (NASDAQ: CBLI) through any online brokerage.
The latest price target for Cleveland BioLabs (NASDAQ: CBLI) was reported by Cantor Fitzgerald on 2014-01-24. The analyst firm set a price target for 0.00 expecting CBLI to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Cleveland BioLabs (NASDAQ: CBLI) is $5.49 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Cleveland BioLabs.
There is no upcoming split for Cleveland BioLabs.